Chien‐Ting Lin

1.4k total citations
33 papers, 739 citations indexed

About

Chien‐Ting Lin is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Chien‐Ting Lin has authored 33 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Oncology and 9 papers in Genetics. Recurrent topics in Chien‐Ting Lin's work include Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Chien‐Ting Lin is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Chien‐Ting Lin collaborates with scholars based in Taiwan, United States and Italy. Chien‐Ting Lin's co-authors include Hwei‐Fang Tien, Shang‐Ju Wu, Shang‐Yi Huang, Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Hsin‐An Hou, Bor‐Sheng Ko, Woei Tsay and Chien‐Yuan Chen and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Chien‐Ting Lin

31 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien‐Ting Lin Taiwan 16 353 300 195 98 94 33 739
Charlotte Guldborg Nyvold Denmark 18 529 1.5× 364 1.2× 185 0.9× 167 1.7× 132 1.4× 73 982
Kazuko Hirabayashi Japan 12 213 0.6× 340 1.1× 176 0.9× 58 0.6× 26 0.3× 27 783
Xiujin Ye China 16 526 1.5× 326 1.1× 140 0.7× 253 2.6× 161 1.7× 94 984
Vladimir Vainstein Israel 15 236 0.7× 226 0.8× 80 0.4× 283 2.9× 40 0.4× 51 723
Emily Curran United States 16 220 0.6× 278 0.9× 119 0.6× 201 2.1× 69 0.7× 42 765
Ana Alfonso Piérola Spain 13 191 0.5× 323 1.1× 79 0.4× 140 1.4× 50 0.5× 50 839
Alexandros Spyridonidis Greece 20 594 1.7× 281 0.9× 126 0.6× 272 2.8× 51 0.5× 75 1.1k
Shengli Xue China 14 354 1.0× 279 0.9× 103 0.5× 319 3.3× 43 0.5× 115 804
Sandra Quijano Colombia 13 143 0.4× 148 0.5× 250 1.3× 149 1.5× 236 2.5× 40 661
Barbara Scarpati Italy 12 183 0.5× 129 0.4× 203 1.0× 75 0.8× 169 1.8× 23 561

Countries citing papers authored by Chien‐Ting Lin

Since Specialization
Citations

This map shows the geographic impact of Chien‐Ting Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Ting Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Ting Lin more than expected).

Fields of papers citing papers by Chien‐Ting Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Ting Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Ting Lin. The network helps show where Chien‐Ting Lin may publish in the future.

Co-authorship network of co-authors of Chien‐Ting Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Ting Lin. A scholar is included among the top collaborators of Chien‐Ting Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Ting Lin. Chien‐Ting Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chien‐Ting, et al.. (2025). The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells. Human Vaccines & Immunotherapeutics. 21(1). 2447141–2447141.
2.
3.
Wu, Shang‐Ju, et al.. (2023). Immunotherapeutic potential of blinatumomab-secreting γ9δ2 T Cells. Translational Oncology. 31. 101650–101650. 3 indexed citations
4.
Yao, Chi‐Yuan, Chien‐Ting Lin, Marcus J. Calkins, et al.. (2022). Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis. Annals of Hematology. 101(10). 2209–2218. 5 indexed citations
5.
Wang, Yuwen, Cheng‐Hong Tsai, Chien‐Chin Lin, et al.. (2020). Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax. Annals of Hematology. 99(3). 501–511. 55 indexed citations
6.
Tien, Feng‐Ming, Cheng‐Hong Tsai, Jia‐Hau Liu, & Chien‐Ting Lin. (2019). Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan. Journal of the Formosan Medical Association. 118(10). 1466–1470. 3 indexed citations
7.
8.
Chen, Chien‐Hung, Ming Yao, Chi‐Cheng Li, et al.. (2019). Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study. British Journal of Haematology. 186(1). 72–85. 8 indexed citations
9.
10.
Lin, Chien‐Ting, Po‐Ren Hsueh, Shang‐Ju Wu, et al.. (2018). Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial. Biology of Blood and Marrow Transplantation. 24(11). 2310–2315. 4 indexed citations
11.
12.
Wu, Shang‐Ju, Chien‐Ting Lin, Andreas Agathangelidis, et al.. (2017). Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications. Haematologica. 102(6). 1085–1090. 24 indexed citations
13.
Lin, Chien‐Ting, et al.. (2016). Dual‐Targeted Photopenetrative Delivery of Multiple Micelles/Hydrophobic Drugs by a Nanopea for Enhanced Tumor Therapy. Advanced Functional Materials. 26(23). 4169–4179. 16 indexed citations
14.
Cheng, Chieh‐Lung, Chi-Cheng Li, Hsin‐An Hou, et al.. (2015). Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults. BMC Cancer. 15(1). 344–344. 43 indexed citations
15.
16.
Wu, Shang‐Ju, Chun‐Ju Chiang, Chien‐Ting Lin, Hwei‐Fang Tien, & Mei‐Shu Lai. (2013). Improving but Inferior Survival in Patients with Chronic Lymphocytic Leukemia in Taiwan: A Population-Based Study, 1990–2004. PLoS ONE. 8(4). e62930–e62930. 12 indexed citations
17.
18.
Wu, Shang‐Ju, Yuan‐Yeh Kuo, Hsin‐An Hou, et al.. (2012). The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution. Blood. 120(15). 3106–3111. 109 indexed citations
19.
Lin, Chien‐Ting, et al.. (2006). The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population. Journal of Human Genetics. 51(10). 857–863. 25 indexed citations
20.
Chang, Hsin‐Hou, et al.. (2005). The integrin α6β1 modulation of PI3K and Cdc42 activities induces dynamic filopodium formation in human platelets. Journal of Biomedical Science. 12(6). 881–898. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte Guldborg Nyvold Breakdown of academic impact, for papers by Kazuko Hirabayashi Breakdown of academic impact, for papers by Xiujin Ye Breakdown of academic impact, for papers by Vladimir Vainstein Breakdown of academic impact, for papers by Emily Curran Breakdown of academic impact, for papers by Ana Alfonso Piérola Breakdown of academic impact, for papers by Alexandros Spyridonidis Breakdown of academic impact, for papers by Shengli Xue Breakdown of academic impact, for papers by Sandra Quijano Breakdown of academic impact, for papers by Barbara Scarpati
Rankless by CCL
2026